Login
Search
Search
0 Dates
2024
2023
2022
2021
2020
2019
2018
0 Events
CPC 2018
CPC 2019
Curso de Atualização em Medicina Cardiovascular 2019
Reunião Anual Conjunta dos Grupos de Estudo de Cirurgia Cardíaca, Doenças Valvulares e Ecocardiografia da SPC
CPC 2020
CPC 2021
CPC 2022
CPC 2023
CPC 2024
0 Topics
A. Basics
B. Imaging
C. Arrhythmias and Device Therapy
D. Heart Failure
E. Coronary Artery Disease, Acute Coronary Syndromes, Acute Cardiac Care
F. Valvular, Myocardial, Pericardial, Pulmonary, Congenital Heart Disease
G. Aortic Disease, Peripheral Vascular Disease, Stroke
H. Interventional Cardiology and Cardiovascular Surgery
I. Hypertension
J. Preventive Cardiology
K. Cardiovascular Disease In Special Populations
L. Cardiovascular Pharmacology
M. Cardiovascular Nursing
N. E-Cardiology / Digital Health, Public Health, Health Economics, Research Methodology
O. Basic Science
P. Other
0 Themes
01. History of Cardiology
02. Clinical Skills
03. Imaging
04. Arrhythmias, General
05. Atrial Fibrillation
06. Supraventricular Tachycardia (non-AF)
07. Syncope and Bradycardia
08. Ventricular Arrhythmias and Sudden Cardiac Death (SCD)
09. Device Therapy
10. Chronic Heart Failure
11. Acute Heart Failure
12. Coronary Artery Disease (Chronic)
13. Acute Coronary Syndromes
14. Acute Cardiac Care
15. Valvular Heart Disease
16. Infective Endocarditis
17. Myocardial Disease
18. Pericardial Disease
19. Tumors of the Heart
20. Congenital Heart Disease and Pediatric Cardiology
21. Pulmonary Circulation, Pulmonary Embolism, Right Heart Failure
22. Aortic Disease
23. Peripheral Vascular and Cerebrovascular Disease
24. Stroke
25. Interventional Cardiology
26. Cardiovascular Surgery
27. Hypertension
28. Risk Factors and Prevention
29. Rehabilitation and Sports Cardiology
30. Cardiovascular Disease in Special Populations
31. Pharmacology and Pharmacotherapy
32. Cardiovascular Nursing
33. e-Cardiology / Digital Health
34. Public Health and Health Economics
35. Research Methodology
36. Basic Science
37. Miscellanea
0 Resources
Abstract
Slides
Vídeo
Report
CLEAR FILTERS
Custos da implantação percutânea de válvula aórtica e do seu comparador
Session:
Sessão de Posters 34 - Medicina Cardiovascular: Para além dos cardiologistas
Speaker:
Catarina Caçador
Congress:
CPC 2024
Topic:
P. Other
Theme:
37. Miscellanea
Subtheme:
34.3 Health Economics
Session Type:
Cartazes
FP Number:
---
Authors:
Catarina Caçador; Julian Perelman
Abstract
<p>Background: Aortic valve stenosis (EVAo) is the most common primary valvular disease in industrialized countries, associated with high rates of morbidity and mortality. Transcatheter aortic valve replacement (TAVI) appears to be non-inferior on patients with severe symptomatic EVAo and moderate surgical risk, in comparison with surgical aortic valve replacement (SAVR). However, according to the international literature, this intervention seems to be associated with higher costs. The investigation aims at measuring and valuing the resources associated with TAVI and its comparator in patients with severe symptomatic EVAo and moderate surgical risk, in light of current practice in Portugal.<br /> Methods: A questionnaire was applied to three groups of experts involved in both interventions during the periods included in the follow-up of each of the interventions under study. Data on clinical events occurring in the first and second years of follow-up were extracted from the clinical trial PARTNER IIA Trial. For the valuation of costs, official documents issued by the Portuguese Government were consulted, as well as literature with national data.<br /> Results: The TAVI intervention was associated with higher costs, compared to SAVR (34 479,15€ versus 19 769,82€), with the cost of the percutaneous prosthesis being the main cost driver. Regarding other dimensions, the highest costs were associated with SAVR, mainly due to clinical events that occurred in the post-intervention periods.<br /> Conclusions: The price of the percutaneous prosthesis was the factor that most influenced the costs of TAVI, which were much higher than the costs of SAVR. In order to justify its dissemination to a greater number of individuals, data will be needed to attest the clear clinical benefit of this technique.</p>
Slides
Our mission: To reduce the burden of cardiovascular disease
Visit our site